Aarti Drugs announced a decline in standalone net profit for the quarter ended June 2015. During the quarter, the profit of the company declined 1.10% to Rs 170.50 million from Rs 172.40 million in the same quarter previous year.
Revenues for the quarter rose marginally 1.53% to Rs 2,636.70 million, compared with Rs 2,597 million for the prior year period.
Operating margin for the quarter stood at 13.21 percent as compared to 12.50 percent for the previous year period. Operating Income for the quarter was Rs 348.40 million, compared with Rs 324.5 million in the previous year period.
Earnings per share for the quarter stood at Rs 7.04, registering 1.12% decline over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Jun - 15 | Jun - 14 | %Change |
| Revenues | 2,636.70 | 2,597.00 | 1.53 |
| Net Profit | 170.50 | 172.40 | (1.10) |
| Diluted EPS | 7.04 | 7.12 | (1.12) |
Shares of the company declined Rs 41.15, or 5.51%, to trade at Rs 705.00. The total volume of shares traded was 61,361 at the BSE (3.32 p.m., Friday).
